This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coulon, P.
Right arrow Articles by Tuffereau, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulon, P.
Right arrow Articles by Tuffereau, C.

 Previous Article  |  Next Article 

J. Virol., 01 1998, 273-278, Vol 72, No. 1
Copyright © 1998, American Society for Microbiology

An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro

P Coulon, JP Ternaux, A Flamand and C Tuffereau
Laboratoire de Genetique des Virus, Centre National de la Recherche Scientifique, Gif sur Yvette, France.

An antigenic double mutant of rabies virus (challenge virus standard [CVS] strain) was selected by successive use of two neutralizing antiglycoprotein monoclonal antibodies, both specific for antigenic site III. This mutant differed from the original virus strain by two amino acid substitutions in the ectodomain of the glycoprotein. The lysine in position 330 and the arginine in position 333 were replaced by asparagine and methionine, respectively. This double mutant was not pathogenic for adult mice. When injected intramuscularly into the forelimbs of adult mice, this virus could not penetrate the nervous system, either by the motor or by the sensory route, while respective single mutants infected motoneurons in the spinal cord and sensory neurons in the dorsal root ganglia. In vitro experiments showed that the double mutant was able to infect BHK cells, neuroblastoma cells, and freshly prepared embryonic motoneurons, albeit with a lower efficiency than the CVS strain. Upon further incubation at 37 degrees C, the motoneurons became resistant to infection by the mutant while remaining permissive to CVS infection. These results suggest that rabies virus uses different types of receptors: a molecule which is ubiquitously expressed at the surface of continuous cell lines and which is recognized by both CVS and the double mutant and a neuron- specific molecule which is not recognized by the double mutant.


This article has been cited by other articles:

  • Klingen, Y., Conzelmann, K.-K., Finke, S. (2008). Double-Labeled Rabies Virus: Live Tracking of Enveloped Virus Transport. J. Virol. 82: 237-245 [Abstract] [Full Text]  
  • Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R. (2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol. 88: 1302-1314 [Abstract] [Full Text]  
  • Bukreyev, A., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L. (2006). Nonsegmented negative-strand viruses as vaccine vectors.. J. Virol. 80: 10293-10306 [Full Text]  
  • Johnson, N., McKimmie, C. S., Mansfield, K. L., Wakeley, P. R., Brookes, S. M., Fazakerley, J. K., Fooks, A. R. (2006). Lyssavirus infection activates interferon gene expression in the brain. J. Gen. Virol. 87: 2663-2667 [Abstract] [Full Text]  
  • Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Rice, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Thijsse, S., Backus, H. H. J., de Kruif, J., Dietzschold, B., Rupprecht, C. E., Goudsmit, J. (2005). Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants. J. Virol. 79: 9062-9068 [Abstract] [Full Text]  
  • Marissen, W. E., Kramer, R. A., Rice, A., Weldon, W. C., Niezgoda, M., Faber, M., Slootstra, J. W., Meloen, R. H., Clijsters-van der Horst, M., Visser, T. J., Jongeneelen, M., Thijsse, S., Throsby, M., de Kruif, J., Rupprecht, C. E., Dietzschold, B., Goudsmit, J., Bakker, A. B. H. (2005). Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis. J. Virol. 79: 4672-4678 [Abstract] [Full Text]  
  • McKenna, P. M., Pomerantz, R. J., Dietzschold, B., McGettigan, J. P., Schnell, M. J. (2003). Covalently Linked Human Immunodeficiency Virus Type 1 gp120/gp41 Is Stably Anchored in Rhabdovirus Particles and Exposes Critical Neutralizing Epitopes. J. Virol. 77: 12782-12794 [Abstract] [Full Text]  
  • Martinez, I., Rodriguez, L. L., Jimenez, C., Pauszek, S. J., Wertz, G. W. (2003). Vesicular Stomatitis Virus Glycoprotein Is a Determinant of Pathogenesis in Swine, a Natural Host. J. Virol. 77: 8039-8047 [Abstract] [Full Text]  
  • McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., Schnell, M. J. (2002). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. J. Virol. 77: 237-244 [Abstract] [Full Text]  
  • Langevin, C., Tuffereau, C. (2002). Mutations Conferring Resistance to Neutralization by a Soluble Form of the Neurotrophin Receptor (p75NTR) Map outside of the Known Antigenic Sites of the Rabies Virus Glycoprotein. J. Virol. 76: 10756-10765 [Abstract] [Full Text]  
  • Mebatsion, T. (2001). Extensive Attenuation of Rabies Virus by Simultaneously Modifying the Dynein Light Chain Binding Site in the P Protein and Replacing Arg333 in the G Protein. J. Virol. 75: 11496-11502 [Abstract] [Full Text]  
  • Badrane, H., Tordo, N. (2001). Host Switching in Lyssavirus History from the Chiroptera to the Carnivora Orders. J. Virol. 75: 8096-8104 [Abstract] [Full Text]  
  • Badrane, H., Bahloul, C., Perrin, P., Tordo, N. (2001). Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity. J. Virol. 75: 3268-3276 [Abstract] [Full Text]  
  • Jallet, C., Jacob, Y., Bahloul, C., Drings, A., Desmezieres, E., Tordo, N., Perrin, P. (1999). Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential. J. Virol. 73: 225-233 [Abstract] [Full Text]  
  • Tuffereau, C., Benejean, J., Alfonso, A.-M. R., Flamand, A., Fishman, M. C. (1998). Neuronal Cell Surface Molecules Mediate Specific Binding to Rabies Virus Glycoprotein Expressed by a Recombinant Baculovirus on the Surfaces of Lepidopteran Cells. J. Virol. 72: 1085-1091 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»